NSB vs PHX

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

NSB

NEUROSCIEN FPO [NSB]

54MEDIUM

PHX

PHARMX FPO [PHX]

54MEDIUM

Score Breakdown

NSB PHX
Technical
42
28
Catalyst
51
51
Sentiment
50
50
Fundamental
72
78
Momentum
36
45
Risk Gate
50
50

Key Metrics

NSB Metric PHX
$24.9MMarket Cap$56.6M
260KAvg Volume (20d)177K
N/AShort InterestN/A
$0.19052-Week High$0.200
$0.05552-Week Low$0.084
-6.2%Daily Change+0.0%
$0.061Reference Price$0.088
-29.7%ROE-9.3%
N/AProfit Margin-24.0%

Active Signals

NSB Signals

Above-average volume (1.9x) on a red day — sellers in control
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (7 quarters)
4C filed 2026-07-28
Very high P/S ratio (61.9x)
Strong revenue growth (+88%)

PHX Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Volume surging at 5.5x normal while price falls — heavy selling pressure
Took a hit — down 12.0% over the last 5 days
Lagging the Small Ords index — relative strength of 0.90, underperforming its peers

Ask Scout AI to compare NSB and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EPI vs PHX →AGN vs PHX →EPI vs NSB →AGN vs NSB →AGN vs EPI →
NSB Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).